- Country: USA
- Summary: Notice of Intent to Sole Source - Pharmaceuticals Duodote
- UST Ref No: 88926172
- Deadline: 18 Sep 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Office of Resource Management (ORM), Strategic National Stockpile (SNS) intend to use other than full and open competition to award a sole source contract to Meridian Medical Technologies, LLC to provide DuoDote Single Dose Autoinjector due to unexpected FDA testing failures of Antidote Nerve Agent Autoinjector (ATNAA) which has caused and inventory shortage and denial to State and local agencies that depend on SNS medical countermeasures used for medical and national emergencies.
This notice of intent to award a sole source contract will be posted for five (5) calendar days to verify that no other sources can meet this requirement given only one responsible source and no other supplies or services will satisfy the Government requirements. This five (5) calendar day notice shall expire on September 18, 2023 at 12:00 PM Eastern Standard Time.
If no credible responses to the intent to sole source are received, the Government intends negotiate a fixed price contract to Meridian Medical Technologies, LLC. The proposed contract action will
support supplies and services for which the Government intends to solicit and negotiate with only one source under the authority of the Federal Acquisition Regulation (FAR) 6.302-1 entitled Only one responsible source and no other supplies or services will satisfy agency requirements, 41 U.S.C. 3304(a)(3). This notice of intent is NOT a request for competitive proposals.
Interested parties may identify their interest and capability to respond to this requirement by submitting in writing their name, address, telephone number, email, and a statement regarding capability to provide the specified requirement.
Responses shall be limited to ten (10) pages or less, including all attachments. Interested parties will be considered only if they respond to this notice with clear and c... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNotice of Intent to Sole Source - Pharmaceuticals Duodote - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Notice of Intent to Sole Source - Pharmaceuticals Duodote. This tender is published on USARFP under UST Ref No: 88926172 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-09-18.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
